200PLiposomal irinotecan (nal-IRI) plus 5-FU/LV in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) progressing on gemcitabine-based treatment: Further subgroup analyses of the pivotal NAPOLI-1 study
Chen, L-T, Macarulla Mercadé, T, Lee, K-H, Lakatos, G, Wang-Gillam, A, Mirakhur, B, de Jong, FVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy432.051
Date:
November, 2018
Fichier:
PDF, 76 KB
2018
File converter
Plus de résultats de recherche
More benefits 
